Soficitinib
Soficitinib (Compound 20) is a selective inhibitor targeting tyrosine kinase 2 (TYK2) and Janus kinase 2 (JAK2), with IC50 values of 0.5 nM and 1.2 nM, respectively. It holds potential for research in autoimmune diseases such as psoriasis and rheumatoid arthritis, as well as inflammatory conditions.
Product Specifications
CAS Number
2574524-67-5
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Smiles
C[C@]12[C@] (CN (C1) C3=NC (NC=4C=NN (C) C4) =NC=C3Cl) (CN (C (CC#N) =O) C2) [H]
Molecular Formula
C18H21ClN8O
Molecular Weight
400.87
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog